You are here

Reporting Patterns and Results of Initial Antibiotic Treatment in Patients With cUTI, cIAI,NP Including VAP

Last updated on February 22, 2019

FOR MORE INFORMATION
Study Location
Research Site
Belo Horizonte, , Brazil
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Urinary Tract Infection (cUTI), Intra-abdominal Infection (cIAI) and, Nosocomial Pneumonia (NP)
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

ICF to be obtained (refer slides 26-30) Adult (≥18 years) patients Patients with a
diagnosis of at least one of the three conditions hospitalised during the period July 1,
2013 to June 30, 2014 Hospital acquired or healthcare associated cUTI Hospital acquired or
healthcare associated cIAI NP including VAP

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

The patient participated in a clinical trial during the patient selection period
(01-Jul-2013 to 30-Jun-2014) or during the follow-up period* For patients diagnosed with
cUTI: The patient has a diagnosis of hospital acquired or healthcare associated cUTI with
concomitant presence of Fungal UTI with colony count > 10^3/mL

NCT02364284
Pfizer
Completed
Reporting Patterns and Results of Initial Antibiotic Treatment in Patients With cUTI, cIAI,NP Including VAP

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now